SLT

PROCEDURE5 trials

Sponsors

University of Calgary, Glaukos Corporation, Aurolab, Vastra Gotaland Region

Conditions

Exfoliation SyndromeGlaucomaGlaucoma, Open-AngleOcular HypertensionOpen-angle GlaucomaPseudoexfoliation Glaucoma

Phase 3

Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension

CompletedNCT01126203

University of CalgaryExfoliation Syndrome, Ocular Hypertension

Start: 2006-09-30End: 2009-10-31Updated: 2010-05-24

Unknown Phase

Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty

CompletedNCT01444105

Glaukos CorporationOpen-angle Glaucoma

Start: 2011-09-30End: 2019-04-09Updated: 2022-08-31

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

AurolabGlaucoma

Start: 2011-10-31End: 2014-12-31Target: 600Updated: 2012-07-13

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

Active, not recruitingNCT03798223

Vastra Gotaland RegionGlaucoma, Open-Angle, Ocular Hypertension, Pseudoexfoliation Glaucoma

Start: 2019-01-10End: 2027-12-31Updated: 2025-10-03

Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial

Enrolling by invitationNCT05159960

Vastra Gotaland RegionGlaucoma, Open-Angle, Ocular Hypertension, Pseudoexfoliation Glaucoma

Start: 2022-01-10End: 2027-12-31Target: 400Updated: 2025-09-30